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Simian virus 40 (SV40) large tumor antigen (T antigen) stimulates the activity of the SV40 late promoter and
a number of cellular and other viral promoters. We have characterized the ability of T antigens with mutations
in the DNA-binding domain and within the N-terminal 85 residues to activate the SV40 late promoter. T
antigens lacking both nonspecific and sequence-specific DNA-binding activities were able to induce the late
promoter. Mutations within the N-terminal 85 residues of T antigen diminished activation by less than twofold.
Activation by wild-type and most of the mutant T antigens required intact binding sites for the cellular
transcription factor TEF-1 in the late promoter. Curiously, two mutants altered in the N-terminal region and
an additional mutant altered in the DNA-binding domain activated a late promoter derivative lacking TEF-1
binding sites, indicating the existence of a TEF-1-independent pathway for activation of the late promoter. A
consensus binding site for the TATA binding protein, TBP, was created in variants of late promoters either
containing or lacking TEF-1 binding sites. Basal expression was increased by the consensus TBP binding site
only when TEF-1 binding sites were present, leading to a reduction in the degree of activation by T antigen.
However, activation by a mutant T antigen of the promoter lacking TEF-1 sites was unchanged or slightly
enhanced by the consensus TBP binding site. These results suggest that some mutant T antigens can stabilize
an interaction between TBP and additional factors bound to the late promoter.
TBP could theoretically activate all RNA polymerase II promoters, when examined specifically this interaction was found
to be able to generate only a fraction of the activity of wild-type
T antigen on the SV40 late promoter or a simple promoter
dependent on TEF-1 binding sites (22). Interaction of T antigen with non-DNA-binding proteins can also result in the
activation of transcription factors. In particular, T antigen
binding to the retinoblastoma susceptibility gene product (Rb)
(16) leads to the release of E2F from a complex with Rb and
to the activation of promoters containing E2F binding sites
(12, 13). Because T antigen itself is a sequence-specific DNAbinding protein (42), it might also directly activate transcription from promoters containing its own binding sites. However,
binding to DNA must not be absolutely required for activation
of the SV40 late promoter, since mutants with truncations that
completely remove the DNA-binding domain retain partial
transactivation activity (22, 60). Nevertheless, it remained possible that binding to DNA assists in activation. In the context
of full-length T antigen, mutants with mutations that interfere
with DNA-binding activity have been reported to be defective
in activation of the late promoter (6, 26, 60). Finally, mutations
in the amino-terminal 85 amino acids of T antigen decrease
induction of the Rous sarcoma virus long terminal repeat
(RSV LTR) and the SV40 late promoter (60). This region also
contains an activity that contributes to the immortalization and
transformation of some cell types (39, 41, 59).
The SV40 late promoter is located in a region of the SV40
genome that also includes the SV40 early promoter and the
viral origin of DNA replication. T antigen activates the late
promoter through a replication-independent stimulation of
late promoter activity (6, 26). Mutagenesis of the late promoter
has indicated that binding sites for the cellular transcription
factor TEF-1 are necessary for activation by T antigen (11, 17,

Simian virus 40 (SV40) large tumor antigen (T antigen) is a
multifunctional protein required for viral DNA replication and
the temporal regulation of viral transcription during SV40 infection. In addition to having a role in the regulation of the
SV40 promoters, large T antigen increases the rate of transcription initiation by RNA polymerase II at a variety of cellular and viral promoters in transient transfection assays (1, 6,
9, 15, 26, 34, 40, 56). Induction of this wide range of promoters
could result from a single function of T antigen that affects
many different promoters, for instance, altering the activity or
enhancing the binding of an essential basal transcription factor. Alternatively, it could result from multiple independent
functions of T antigen, each affecting the activity of a different
promoter-specific transcription factor. Analysis of the functions of T antigen suggests that both models may be true. T
antigen contains several activities, described below, that can
regulate transcription (2, 12, 13, 16, 22, 30, 31, 35, 37, 42, 43,
45, 60). The activity of several DNA-binding transcription factors can be altered either directly or indirectly by T antigen. At
least four cellular transcription factors interact directly with T
antigen: the sequence-specific DNA-binding transcription factors AP-2 (38), TEF-1 (22), and p53 (30, 31) and the TATA
binding component (TBP) of the basal transcription factor
TFIID (22, 35). Although the interaction of T antigen with
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27, 28, 47). In addition, these sites are sufficient to confer
T-antigen inducibility on heterologous promoters (11, 21, 22).
T antigen interacts directly with both TEF-1 and TBP, and
induction of the late promoter is abolished with T-antigen
fragments that fail to bind either of these factors, with a single
exception (22). Although TEF-1 binding sites are clearly necessary for induction of the late promoter, other sequences have
been identified that also contribute to activation (7, 17, 18, 27,
36, 47). These include sequences in the enhancer and 21-bp
repeats, as well as sequences at the origin of DNA replication.
The presence of several elements which can contribute to induction of the late promoter suggests that multiple activities of
T antigen are involved in late promoter activation.
Using mutants of T antigen, we have examined the role of
the DNA-binding activity and of the N-terminal 85 residues of
T antigen in activation of the SV40 late promoter. Our results
show that in the context of full-length T antigen, DNA-binding
activity is not necessary for activation of the late promoter.
Unexpectedly, we found three mutants that strongly activated
a derivative of the SV40 late promoter lacking TEF-1 binding
sites, indicating the existence of a second pathway for activation of the late promoter.
MATERIALS AND METHODS
Plasmid DNA. All plasmids were propagated in Escherichia coli HB101, isolated by an alkaline lysis protocol (4), and purified twice by centrifugation in
CsCl-ethidium bromide gradients.
The plasmid pLCATD72 was constructed from pL16nCAT (27) by cleavage
with SphI, which deleted one of the two 72-bp repeats. Mutations in pLCATD72
were made in the TEF-1 binding sites, the TATA box, or both to generate
TEFCAT1,2,3 (11), pLCAT3181, and TEFCAT3181, respectively (see Fig. 5 for
sequences). Mutagenesis was performed by using a site-directed mutagenesis kit
(Amersham) according to the manufacturer’s instructions. The template was a
single-stranded M13 derivative, including the origin of DNA replication and both
the early and late promoters with only a single 72-bp repeat (SV40 nucleotides
[nt] 4770 to 874, except for a deletion of nt 107 to 179). Subsequently, DNA
fragments containing the mutations were used to replace the analogous wild-type
sequences in pLCATD72. The parental (pLCATD72) DNA and mutant derivatives therefore contain SV40 sequences from nt 5171 to 107 and nt 179 to 333,
with the late promoter driving expression of the bacterial chloramphenicol
acetyltransferase (CAT) gene. A 6-bp deletion at the origin of replication prevents replication-induced amplification in the presence of wild-type T antigen or
replication-competent mutant T antigens (19). The sequence of the DNA in the
promoter regions was confirmed for each isolate by the dideoxynucleotide sequencing method (46) with the enzyme Sequenase (United States Biochemicals).
The 2400 and 2800 series of mutant T antigens (60, 61) and the set of point
mutations in the DNA-binding domain (50–52) have been described previously.
Mutant dl888 (49) and RSV t/cDNA (32) express only large T and small t
antigens, respectively. All the expression plasmids for large T antigen utilize the
SV40 early promoter to promote expression and contain a mutation at the origin
of replication to prevent replication in the presence of wild-type T antigen.
Transfection mixtures included plasmids containing the human growth hormone gene under control of either the herpes simplex virus thymidine kinase
promoter (pTKGH) or the mouse metallothionein I promoter (pXGH5) as
general indicators of transfection efficiency (48). Growth hormone levels were
determined by radioimmune assays with a kit from Nichols Institute Diagnostics.
The data presented are not normalized by the levels of secreted growth hormone,
however, because a correlation was found between the ability of a given T
antigen to activate the SV40 late promoter and its ability to activate the promoters in pTKGH or pXGH5 (see also Discussion in reference 18). The pXGH5
and pTKGH promoters were activated from 1.5- to 2-fold and about 4-fold,
respectively, by wild-type T antigen. Thus, correction for growth hormone levels
would lower the apparent fold activation and minimize differences between the
various mutants. We note that the lack of correction for transfection efficiency
increases the ranges of the fold activation by wild-type or mutant T antigens
when the data from multiple experiments are compared.
Cell culture and transfection assays. CV-1 cells were maintained in Dulbecco’s modified Eagle medium (Hazelton) with 10% (vol/vol) newborn calf serum
(Gibco), 50 U of penicillin G per ml, and 50 mg of streptomycin (Gibco) per ml.
Transfections were performed by the calcium phosphate precipitation method
(20), modified as described previously (11). Transfection mixtures generally
included 2 mg of CAT reporter plasmid DNA; 0 or 2 mg of either p6-1, to express
wild-type T antigen, or plasmids encoding mutant T antigens; 0.5 mg of pXGH5
or pTKGH; and pBluescript SK1 (Stratagene) to bring the total amount of DNA
to 20 mg/10-cm-diameter plate. Cells were harvested between 40 and 45 h fol-
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FIG. 1. Location of T-antigen mutations. A schematic diagram of SV40 T
antigen and the location of specific mutations is shown. The lightly shaded region
in the uppermost rectangle represents the 82-residue sequence shared between
large T and small t antigens. The domains of T antigen required for its functions
discussed in the text are indicated by shaded boxes below the uppermost rectangle. The minimal region able to bind TEF-1 extends from residues 5 to 383.
The region extending from residues 5 to 172 contains at least two independent
TBP binding segments: residues 5 to 82 and residues 82 (22) or 100 (25) to 172.
The minimal region able to specifically bind DNA extends from residues 131 to
259. Mutants indicated below the uppermost rectangle represent in-frame deletion mutations, and mutants indicated above the rectangle represent in-frame
insertion and substitution mutations. Four additional mutants are mentioned in
the text, but no data for these are shown. Of these, mutants 204RK, 205VL, and
207RK contain the indicated amino acid substitutions (e.g., K for R) at residues
204, 205, and 207, respectively. Mutant inA2817 contains a 4-amino-acid insertion at residue 219.

lowing the addition of the DNA. Assays for CAT activity were performed as
previously described with 50 to 100 mg of extracted protein (11). The amount of
protein per assay was constant for each experiment. The conversion of chloramphenicol to acetyl-chloramphenicol was quantitated with a phosphorimager
(model 400E; Molecular Dynamics). The percent conversion ranged from 0.5 to
35%, which is within the linear range of this assay.
Western immunoblot analysis. Nuclear extracts from transfected cells were
prepared for analysis of the levels of wild-type and mutant T antigens in transfected cells. Transfected cells were washed twice with phosphate-buffered saline
and then allowed to swell on ice for 10 min in 2 ml of hypotonic buffer (10 mM
HEPES [N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic acid], pH 7.9–1.5 mM
MgCl2–10 mM KCl–0.5 mM phenylmethanesulfonyl fluoride). The cells were
harvested by scraping, transferred to a Dounce homogenizer, and lysed by six
strokes with the B pestle. The nuclei were immediately pelleted for 20 s at 5,000
3 g and resuspended in 50 ml of 20 mM HEPES–1.5 mM MgCl2–0.5 mM
dithiothreitol–0.2 mM EDTA–420 mM NaCl–0.5 mM phenylmethanesulfonyl
fluoride–25% glycerol. The nuclei were extracted for 20 min on ice and then
centrifuged for 5 min at 16,000 3 g. The supernatant was used for immunoblot
analysis. A 10-mg amount of nuclear extract was separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis, and the separated proteins were electrophoretically transferred to Immobilon-P filters (Millipore) in 25 mM TrisHCl, pH 8.0–192 mM glycine–20% (vol/vol) methanol. The filters were blocked
for 30 min with 3% bovine serum albumin in TBS (10 mM Tris-HCl, pH 8.0–150
mM NaCl) and then incubated for 5 h with a 1:1,000 dilution of pAb419 or
pAb423 (obtained from M. Bradley and J. DeCaprio) (23) in TBS containing
0.05% Tween 20. T antigen was detected with alkaline phosphatase-conjugated
goat anti-mouse antisera (Bio-Rad) according to the manufacturer’s instructions.

RESULTS
We tested the ability of T antigens carrying mutations in the
DNA-binding domain or in the N-terminal 85 residues to activate the SV40 late promoter. Plasmids encoding either wildtype SV40 large T antigen (p6-1) (61) or mutant T antigens
were cotransfected into CV-1 cells with CAT reporter plasmids
carrying the SV40 late promoter lacking one 72-bp repeat
(pLCATD72) or the same promoter in which all three binding
sites for the cellular transcription factor TEF-1 were mutated
(TEFCAT1,2,3) (11). The locations of the mutations in T antigen are diagrammed in Fig. 1. Because wild-type SV40 T
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antigen and some of the mutant T antigens will promote replication of DNA containing SV40 origin sequences, the SV40
origin of replication in all the reporter plasmids was mutated
(19). The amount of T antigen produced in transfected cells
was quantitated by Western blot analysis of nuclear extracts
with either antibody pAb419 or pAb423, which bind epitopes
near the amino-terminal and carboxyl-terminal regions of T
antigen, respectively (23).
DNA-binding activity is not necessary for activation of the
SV40 late promoter. T antigen possesses both nonspecific (50,
52) and sequence-specific (42) DNA-binding activities, and the
SV40 origin region contains specific binding sites (site I and
site II) for T antigen (24, 42, 55). The region including the
origin binding sites has been shown to play a role in T-antigen
activation of the late promoter provided that sequences within
the SV40 enhancer are also present (7, 27). Although T-antigen binding site II at the origin of replication was mutated in
the reporter plasmids used in this study, T antigen might still
interact either specifically through T-antigen binding site I or
nonspecifically. Thus, three types of T-antigen mutants were
tested in transfection assays: those defective in sequence-specific binding but which retain nonspecific DNA-binding activity
(inA2815, dlA2411 [60, 61], 153NS, and 204RK [52]), those
defective in both specific and nonspecific binding activities
(187HR, 149AG, 185ST, 203HN, and 226VA [51, 52]), and
several competent for both specific and nonspecific DNA binding (205VL, 207AG [51, 52], and inA2817 [60, 61]). We determined the effects of these mutants both on the parental SV40
late promoter (pLCATD72) and on this promoter with mutated TEF-1 sites (TEFCAT1,2,3). Initially, we measured the
response of the parental late promoter to increasing levels (0.5
to 4.0 mg) of plasmid DNAs encoding either wild-type T antigen or mutant 153NS, which lacks sequence-specific DNAbinding activity but retains the ability to interact nonspecifically with DNA (10). The results we obtained indicated that
the levels of DNA transfected were within the linear range of
response. A similar titration of plasmid DNA (0.66 to 6.0 mg)
encoding the mutant T antigen 149AG, which does not interact
specifically or nonspecifically with DNA, indicated that transfected amounts of this DNA were also below saturating levels
for the assay (10).
The results of multiple transfection experiments using a
fixed amount (2 mg) of DNA encoding several different mutants, in conjunction with either the parental or the mutated
SV40 late promoter, are shown in Fig. 2. Levels of CAT activity
expressed from the promoters in the presence of each mutant
T antigen are normalized to the levels of expression in the
presence of wild-type T antigen. Wild-type T antigen (p6-1)
induced pLCATD72 ninefold in these experiments (Fig. 2A,
compare each p6-1 with each 2T/t) and did not induce TEFCAT1,2,3 (Fig. 2B), confirming that the induction is dependent
on TEF-1 binding sites (11, 18, 28). Mutant 153NS activated
the late promoter to roughly the same extent as the wild-type
T antigen did, demonstrating that sequence-specific DNAbinding activity is not necessary for efficient transcriptional
induction. A similar result was obtained with mutant 204RK
(data not shown), whose T antigen lacks specific DNA-binding
activity but retains the ability to bind DNA nonspecifically
(52). The other two mutants lacking specific DNA-binding
activity, inA2815 and dlA2411, also activated pLCATD72, albeit at substantially reduced levels. These last-mentioned data
differ from those of Zhu et al. (60), who found that both
dlA2411 and inA2815 failed to induce the late promoter. One
possible explanation for this discrepancy is that different mechanisms of transactivation of the SV40 late promoter are utilized in different CV-1 cell subclones (see Discussion).
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FIG. 2. T-antigen DNA-binding activity is not necessary for activation of the
SV40 late promoter. The bars represent CAT activity directed by pLCATD72
(A) and TEFCAT1,2,3 (B) reporter plasmids in cells cotransfected with plasmids
expressing either wild-type T antigen (p6-1) or mutants lacking DNA-binding
activity (see text). For a given mutant, each bar represents the results of a single
experiment. Identically shaded bars indicate results from transfections that were
performed at the same time. The data have been normalized to the level of CAT
activity in extracts from cells transfected with wild-type large T antigen. In these
experiments, the average level of activation of pLCATD72 by wild-type T antigen
(A) was 9.0-fold. The relative consistency of this degree of activation can be
discerned by the levels of basal transcription (2T/t) that are indicated. The
average basal level (2T/t) of TEFCAT1,2,3 activity was 80% of the average basal
level of pLCATD72 activity. (C) Levels of wild-type and mutant T antigens
expressed in transfected cells. T antigen was detected by Western immunoblot
analysis with the monoclonal antibody pAb419. The prominent band in lanes 2
and 8 (p6-1) has an apparent molecular mass of 89 kDa.
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Surprisingly, mutant 153NS also induced the mutated promoter TEFCAT1,2,3 by three- to sevenfold in these experiments (Fig. 2B, middle group, compare 153NS with 2T/t), an
activity not observed with wild-type T antigen. Although the
153NS mutant T antigen is overexpressed relative to wild-type
T antigen (Fig. 2C, lane 4), it is unlikely that this accounts for
the qualitative change in activity reflected by induction of expression from TEFCAT1,2,3. Mutants inA2815 and dlA2411
did not induce expression of TEFCAT1,2,3.
Among mutants defective in both nonspecific and specific
binding to DNA, 149AG and 226VA effectively induced the
parental SV40 late promoter (from six- to sevenfold and fiveto sixfold, respectively), showing clearly that nonspecific DNAbinding activity is not necessary for activation (Fig. 2A). Cotransfection with TEFCAT1,2,3 confirmed that this activation
required TEF-1 binding sites (Fig. 2B). These data demonstrate conclusively that neither specific nor nonspecific DNAbinding activities of T antigen are required for activation of the
late promoter. As anticipated, the T antigens of mutants that
fully retain DNA-binding activity activated transcription as
well as wild-type T antigen did (205VL, 207AG, and inA2817;
data not shown).
The mutants inA2815 and 187HR activated the wild-type
late promoter particularly poorly. To determine whether the
mutated proteins were stable, immunoblot analysis was performed with nuclear extracts prepared from transfected cells
(Fig. 2C). This analysis showed that the levels of inA2815 and
187HR (Fig. 2C, lanes 5 and 6) were reduced compared with
levels of wild-type T antigen (p6-1, lane 2). It should be noted,
however, that 185ST, which retained the ability to transactivate, was also synthesized at low levels relative to those of
wild-type T antigen (Fig. 2C, lane 10).
Novel phenotype of mutants with alterations in the N-terminal region of T antigen. Mutations in the N-terminal 85
residues of T antigen that reduce the ability of T antigen to
activate transcription from the RSV LTR and the SV40 late
promoter have been identified (60). This region also contains
an activity involved in the immortalization and transformation
of some types of cells (39, 41, 59). Additional evidence suggests
that the transformation function may also regulate transcription (see Discussion). We determined the effect of these mutations on TEF-1-mediated activation of the SV40 late promoter in our cell line. Plasmids encoding insertion mutations at
T-antigen residues 5 (in2801), 35 (inA2803), and 85 (inA2835);
a deletion of residue 85 (dlA2834); or a replacement of residues 5 to 35 with four new residues (dlA2831) were cotransfected with either pLCATD72 or TEFCAT1,2,3 into CV-1 cells.
The levels of expression from these SV40 late promoters are
summarized in Fig. 3A and B, respectively. Two different phenotypes were observed. Mutants in2801, dlA2834, and inA2835
induced CAT expression from the parental late promoter (Fig.
3A) but were unable to induce the TEFCAT1,2,3 promoter
(Fig. 3B). Thus, these mutants have essentially the phenotype
of wild-type T antigen. Surprisingly, mutant dlA2831 induced
CAT expression not only from the parental late promoter but
also from the promoter lacking TEF-1 binding sites (Fig. 3B).
Mutant inA2803 also displayed this phenotype, although in a
less pronounced manner. These effects are not due to overexpression of the mutant proteins, because Western blot analysis
indicated that both mutants dlA2831 and inA2803 are present
at levels lower than those of wild-type T antigen (Fig. 3C, lanes
2, 4, and 5). Although the fold activation of TEFCAT1,2,3 with
dlA2831 was lower than the corresponding activation of
pLCATD72 (Fig. 3A and B, compare dlA2831 data with those
for 2T/t), these results indicate that a TEF-1-independent
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FIG. 3. Activation of the SV40 late promoter via a TEF-1-independent pathway. The bars represent CAT activity directed by pLCATD72 (A) and TEFCAT1,2,3 (B) reporter plasmids upon cotransfection with plasmids expressing
either wild-type T antigen or T antigen with mutations within the N-terminal
region (see text). For a given mutant, each bar represents the results of a single
experiment. Identically shaded bars indicate results from transfections that were
performed at the same time. Data have been normalized as described in the
legend to Fig. 2. Average activation of pLCATD72 by wild-type T antigen in
these experiments was 7.8-fold. Basal expression from TEFCAT1,2,3 was 90% of
the basal expression from pLCATD72. (C) Western immunoblot analysis was
performed as described in the legend to Fig. 2, except that mutant T antigens
encoded by in2801, inA2803, and dlA2831 were detected with the monoclonal
antibody pAb423 instead of pAb419.
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mechanism exists for activation of the SV40 late promoter by
this T antigen.
The mutations in inA2803 and dlA2831 lie within sequences
shared by both large T and small t antigens. Given that t
antigen can positively (5, 32) and negatively (57) regulate RNA
polymerase II transcription, we sought to determine whether
the coincidental mutation of small t antigen could be responsible for the unexpected phenotype of dlA2831. Specifically, if
small t antigen were a repressor of the late promoter, the
mutation in dlA2831 might inactivate the repression activity,
allowing large T antigen to induce transcription through additional pathways not dependent on TEF-1 binding sites. This
model predicts that small t antigen alone would repress both
the parental and mutant late promoters and that large T antigen alone would activate transcription even in the absence of
TEF-1 binding sites. We therefore measured the individual
effects of large T antigen (dl888) (49) and small t antigen
(pRSV-t/cDNA) (32) on expression from parental and TEF1-site-mutated late promoters. Large T antigen alone, but
not small t antigen alone, induced CAT expression from
pLCATD72 (Fig. 4A). In agreement with published data (5),
we found that small t antigen (expressed from pRSV-t/cDNA)
enhanced the activation by large T antigen (expressed from
dl888) of pLCATD72 by two- to fourfold (data not shown).
Therefore, wild-type small t antigen is not an inhibitor of the
parental late promoter, contradicting the first prediction of the
model.
A second prediction of the model is that large T antigen
would activate the late promoter independently of TEF-1 sites
in the absence of small t antigen. We found that transfection
with amounts of dl888 DNA sufficient to maximally activate the
parental promoter had little effect on the mutant promoter
(Fig. 4B). Small t antigen alone caused reduction in TEFCAT1,2,3 activity. This suggests that small t antigen may inhibit T antigen from activating TEFCAT1,2,3 when both large
and small T antigens are present. It is likely, however, that
mutation of large T antigen is required to obtain the mutant
phenotype of inA2803 and dlA2831, since wild-type T antigen
alone did not activate TEFCAT1,2,3.
T antigen can interact directly with TEF-1 and with TBP, the
DNA-binding subunit of the general transcription factor
TFIID (22, 35). TEF-1 also interacts directly with TBP (22).
These observations suggested that T antigen may activate the
late promoter by stabilizing or enhancing the interaction between TEF-1 and TBP. To determine whether TEF-1-independent activation by dlA2831 could be explained by a similar
model, we compared how different TATA elements in the
context of the SV40 late promoter would affect activation by
dlA2831 and wild-type T antigens. The TATA element of
the wild-type SV40 late promoter has a low affinity for TBP
(58). A TATA element with higher affinity for TBP (up mutant), representing an optimal TBP binding site, was created in
both the parental (pLCATD72) and mutated TEF-1 bindingsite (TEFCAT1,2,3) backgrounds by site-directed mutagenesis.
The TATA up mutant used here, 3181 (see Fig. 5C), increases
the rate of initiation at the SV40 late promoter in vitro by
20-fold (8, 54). We tested how these mutated promoters responded in vivo to both wild-type T antigen and dlA2831 (Fig.
5A and B). In the pLCATD72 background, the consensus
TATA sequence stimulated basal expression to a degree less
than what occurred in vitro, with pLCAT3181 expressing levels
only fourfold higher than those expressed by pLCATD72 (Fig.
5A, compare 2T/t bars). These results suggest, however, that a
TATA up mutant does enhance the activity of TFIID at the
late promoter, presumably by maintaining a more stable complex for interaction with other transcription factors. Wild-type
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FIG. 4. Large T antigen, but not small t antigen, activates the SV40 late
promoter. The bars represent CAT activity directed by pLCATD72 (A) and
TEFCAT1,2,3 (B) reporter plasmids upon cotransfection with plasmids expressing large T antigen alone (dl888), small t antigen alone (t cDNA), or both
together (p6-1). For a given mutant, each bar represents the results of a single
experiment. Identically shaded bars indicate results from transfections that were
performed at the same time. The average activation of pLCATD72 by p6-1 in
these experiments was 10-fold. Basal expression from TEFCAT1,2,3 (2T/t) was
80% of the basal expression from pLCATD72. (C) Western immunoblot analysis
of T antigen from cells transfected with dl888 was performed as described in the
legend to Fig. 2.

T antigen activated pLCATD72 an average of sevenfold; this
was reduced to fivefold with pLCAT3181 (Fig. 5A and C).
Induction by dlA2831 was similarly reduced by the TATA up
mutation (Fig. 5A and C).
In a TEFCAT1,2,3 background, the 3181 mutation did not
affect the basal level of expression (Fig. 5B, compare 2T/t
bars), indicating that an altered TATA sequence alone is not
sufficient to increase expression from this promoter. Wild-type
T antigen minimally induced both TEFCAT1,2,3 and TEFCAT3181 in these experiments (Fig. 5B and C). In contrast,
activation by dlA2831 is observed on both promoters, with a
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FIG. 5. Effect of TATA sequence on activation by wild-type T antigen and
dlA2831. (A and B) The bars represent CAT activity directed by the indicated
reporter plasmids, diagrammed in panel C, upon cotransfection with plasmids
expressing either wild-type (p6-1) or mutant (dlA2831) T antigen. (A) Promoters
containing TEF-1 binding sites. (B) Promoters lacking TEF-1 binding sites. For
a given mutant, each bar represents the results of a single experiment. Identically
shaded bars indicate results from transfections that were performed at the same
time. All data in panels A and B are normalized to the level of CAT activity
produced by pLCATD72 in the absence of T antigen (2T/t). (C) The different
SV40 late promoters in the reporter plasmids are diagrammed on the left.
pLCATD72 is identical to the wild-type SV40 776 late promoter except that one
of the two 72-bp repeats and 6 bp at the origin of replication have been removed.
The speckled box represents the remaining 72-bp repeat sequence, and the open
boxes represent the three 21-bp repeat sequences. The positions of TEF-1
binding sites are shown by open ovals, and a mutation in each of these sites is
indicated by ‘‘3 ’’. The sequence beginning at bp 229 relative to the major late
transcription initiation site (arrow) is shown. The values on the right represent
the average degree of activation by each T antigen, as calculated from the data
presented in panels A and B. WT, wild type.

slight increase from fivefold with TEFCAT1,2,3 to sixfold with
TEFCAT3181 (Fig. 5B and C). These results suggest that in
the absence of TEF-1 sites, the mutant T antigen dlA2831
provides an activity that stabilizes the binding of TFIID to the
promoter or allows TFIID bound at the promoter to function
more efficiently. An interpretation consistent with these data is
that dlA2831 stabilizes an interaction between TBP and an
upstream factor bound to the mutated late promoter.
DISCUSSION
We have shown that induction of the SV40 late promoter by
wild-type T antigen does not require the specific or nonspecific
DNA-binding activities of T antigen. We have also shown that
some T-antigen mutants can induce transcription from a late
promoter lacking TEF-1 binding sites, an activity not seen with
wild-type T antigen.
Previous studies have shown that activation of the SV40 late
promoter does not absolutely require T-antigen DNA-binding
activity (22, 60). Similarly, transcriptional activation by T antigen of the SV40 early and late promoters in vitro occurs
efficiently with preparations of T antigen unable to specifically
bind DNA (14). However, analysis of the late promoter has
indicated that the T-antigen binding sites at the origin of replication contribute to activation (7, 27, 36). In addition, several
mutations within T antigen that inhibit its DNA-binding activity resulted in lower levels of activation, also suggesting a role

for DNA-binding activity in transactivation (6, 26, 60). Our
results with specific point mutants clearly demonstrate that
normal activation can occur when both specific and nonspecific
DNA-binding activities are severely reduced. In addition, in
some cases where the level of activation observed with DNAbinding mutants was low (inA2815 and 187HR), the level of
activation correlated with reduced levels of the proteins in
transfected cells. It should be noted, however, that other mutant T antigens expressed at low levels retained transcriptional
activation activity. Two simple explanations for the effects of
some DNA-binding domain mutations on transactivation
could be that sequences in the DNA-binding domain, but not
DNA-binding activity itself, are involved in activation and that
the DNA-binding domain mutations cause aberrant protein
folding. The lack of dependence on the ability of T antigen to
bind DNA does not imply that activation occurs without localization of T antigen to the promoter. In this regard, Gruda et
al. have demonstrated that T antigen will bind directly to in
vitro-translated TBP and TEF-1 and that the regions of T
antigen required for these interactions are also necessary for
activation of the late promoter in vivo (22). Thus, T antigen
may be bound at the promoter indirectly, through proteinprotein interactions, which may be necessary for transactivation of the SV40 late promoter.
An unexpected phenotype was observed upon examination
of mutants altered in the N-terminal 85 amino acids of T
antigen. Previous studies had indicated that these mutants
induced the RSV LTR to 40 to 50% of wild-type levels and the
SV40 late promoter to 40 to 100% of wild-type levels, therefore showing slight defects in transcriptional activation (60). A
comparison between adenovirus E1A and SV40 T antigen provides further support for a role of this region in regulation of
transcription. Sequences at the extreme N terminus of E1A are
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necessary for transformation of BRK cells in conjunction with
an activated ras gene and are also required for binding the
E1A-associated p300 protein (53, 59). Furthermore, the ability
to bind p300 correlates with E1A-mediated inhibition of enhancer activity (53), as well as activation of particular promoters (29). T antigen possesses an activity that complements the
transformation defect conferred by a mutation in the p300
binding region of E1A. Complementation was prevented by
deletion of T-antigen residues 17 to 27 (59). Thus, by analogy
with E1A, the N-terminal region of T antigen may also regulate transcription. Recently, p300 has been shown to be highly
homologous to other transcriptional coactivators (3), strengthening the potential importance of the T-antigen–E1A analogy
for T-antigen transactivation.
In our experiments, mutant T antigens with insertions of 4
amino acids at residue 5 or 85 or a deletion of residue 85 were
able to activate the SV40 late promoter, with activation depending on intact TEF-1 binding sites. However, an insertion
at residue 35 or replacement of residues 5 to 35 with four
different amino acids resulted in activation of transcription
from a promoter lacking TEF-1 binding sites, an activity not
observed with wild-type T antigen. A similar activity was observed with the specific DNA-binding mutant 153NS. The difference between the level of induction by these mutant T
antigens of a wild-type late promoter (5- to 12-fold) versus one
lacking TEF-1 binding sites (3- to 5-fold) suggests that the
TEF-1-dependent mechanism is at least partially intact in these
mutants. In addition, these mutants can activate the late promoter through a pathway not normally used by wild-type T
antigen.
Activation of the late promoter by wild-type T antigen has
been proposed to result from the direct interactions between T
antigen, TEF-1, and TBP (22). We expect that the mutant T
antigens exhibiting a TEF-1-independent phenotype will still
bind to TBP. There are two regions of T antigen that are
sufficient to bind TBP: one localized to the N-terminal 88
residues (22) and a second that is functional even upon deletion of the first 100 residues of T antigen (22, 25). The role of
TBP in TEF-1-independent activation of the late promoter by
dlA2831 was investigated by creating TBP binding sites of
increasing affinities in the context of the SV40 late promoter.
We found that a consensus TBP binding site in the context of
the parental late promoter increased the basal promoter activity, but when the promoter lacked TEF-1 binding sites, the
increased affinity for TBP was not sufficient to increase basal
promoter activity. The apparent requirement for TEF-1 binding sites to obtain a response on basal levels of transcription to
a strong TBP binding site is consistent with a model in which
TEF-1 stabilizes the formation of the preinitiation complex,
presumably through direct interaction with TBP. These data
also suggest that other factors bound to the late promoter do
not stabilize the preinitiation complex in the same manner as
TEF-1 does.
With a strong TBP binding site in pLCATD72, the absolute
levels of promoter activity in the presence of dlA2831 and
wild-type T antigens were increased but the fold activation was
reduced in each case. It is unlikely that the reduced degree of
activation, at least for dlA2831, is due to the late promoter
reaching its maximal activity, because higher CAT expression
levels were obtainable with wild-type T antigen. Alternatively,
the increased affinity for TBP may partially substitute for a
function of T antigen. For example, if the binding of TBP to
the weak SV40 late promoter TATA element is stabilized by T
antigen in conjunction with TEF-1, a higher-affinity binding
site for TBP, in the presence of TEF-1, might suffice to stabi-
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lize binding. This would increase basal transcription and thus
lower the fold activation by T antigen.
However, increasing the affinity of the TBP binding site in
the context of a late promoter lacking TEF-1 binding sites left
unchanged or slightly increased the fold activation by dlA2831.
This is consistent with a model in which dlA2831 facilitates the
interaction of TBP with another factor bound to the late promoter. The model would necessitate that such a factor would
not interact efficiently with TBP in the absence of T antigen,
since basal activity of the promoter lacking TEF-1 sites was not
increased by a strong TBP binding site. In support of this
model, natural promoters lacking TEF-1 binding sites are activated by T antigen through other promoter elements (15, 33).
In addition, a series of synthetic promoters containing binding
sites for several transcription factors combined with different
TATA elements are effectively activated by T antigen (18, 44).
Of note, the degree of activation varies considerably with different TATA boxes.
The apparent absence of the TEF-1-independent activity in
wild-type T antigen in our experiments could be explained in
several ways. First, dlA2831 and inA2803 could have gained a
new function as a result of the insertion of amino acids at
residue 35. We find this possibility unlikely since different
mutants (dlA2831, inA2803, and 153NS) demonstrate a similar
phenotype. Second, sequences around residue 35 may constitute a regulatory domain which normally masks the TEF-1independent mechanism. In this scenario, the mutations in
dlA2831 and inA2803 would relieve the inhibition. If this were
the case, other transcription regulatory functions of T antigen
necessary for TEF-1-independent activation could be mapped
by using these mutants. In this regard, Gruda et al. (22) have
shown that a C-terminal portion of T antigen from residue 379
through residue 707, fused to a portion of GAL4, could activate transcription from the SV40 late promoter. As a third
possibility, these mutations might enhance the normal function of the N-terminal region. For instance, mutations may
strengthen the interaction with a cellular protein that normally
binds to this region, such as p300.
The TEF-1-independent mechanism may be more consequential in other cell lines. We have found that in another
subclone of CV-1 cells (see reference 60), activation of the late
promoter by wild-type T antigen was much less affected by
mutation of the TEF-1 binding sites. dlA2831 also activates
both promoters in these cells (10). Thus, wild-type T antigen
may in fact possess TEF-1-independent activity, which may be
masked in some cell lines.
These results are in accord with the model that several
functions of T antigen can lead to activation of transcription.
We have found that T antigen binding to DNA is not necessary
for activation of the SV40 late promoter in cells where activation is dependent on TEF-1 binding sites. In addition, three
mutant T antigens, two mutated near the amino-terminal region and one mutated in the DNA-binding domain, are able to
activate the late promoter independently of TEF-1 binding
sites. We suggest that these mutants function by promoting the
interaction between TBP and a second factor bound to the late
promoter. This alternate pathway may be important for regulation of promoters that lack TEF-1 binding sites and are
dependent on other promoter elements for induction.
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